Skip to main content
S&P 5007,650.50+0.17%DOW51,682.64-0.18%NASDAQ26,522.54+0.39%BTC$81,104.00+5.94%ETH$2,635.45+7.47%GOLD$4,416.70+0.39%OIL$95.48-1.80%
Smart Investors Daily
BioStem Technologies, Inc. logo

OTC · BSEM

BioStem Technologies, Inc.

Healthcare · Biotechnology

$4.36

Up+$0.38 (+8.72%)

Updated Sep 18, 2026, 8:23 PM

SID Score

3.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
70.33M
P/E ratio
3.5
Dividend yield
0.00%
52-week range
$2.25 – $4.66
Volume
119.65K
Avg. volume
68.56K

Price performance

BSEM price history

1M range · 20 trading sessions · Daily adjusted prices

BSEM closed at $4.36 after 20 trading sessions, up 18.48% for the selected period.

Last close
$4.36
Period change
+18.48%
Period low
$3.50
Period high
$4.36
Daily close
View OHLC price history
BSEM OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 17, 2026$4.18$4.50$4.06$4.36119.65K
Sep 16, 2026$3.96$4.34$3.96$4.0876.37K
Sep 15, 2026$4.15$4.35$3.90$4.01117.04K
Sep 14, 2026$4.41$4.50$4.16$4.21140.51K
Sep 11, 2026$4.23$4.45$4.17$4.31143.08K
Sep 10, 2026$4.13$4.30$4.13$4.17593.85K
Sep 9, 2026$4.05$4.30$4.04$4.21117.7K
Sep 8, 2026$3.88$4.65$3.865$4.00391.83K
Sep 4, 2026$3.63$3.85$3.59$3.7187.49K
Sep 3, 2026$3.56$3.88$3.56$3.61100.39K
Sep 2, 2026$3.50$3.62$3.42$3.5460.76K
Sep 1, 2026$3.68$3.76$3.50$3.5090.43K
Aug 31, 2026$3.50$4.0499$3.50$3.68196.44K
Aug 28, 2026$3.80$3.825$3.53$3.5354.16K
Aug 27, 2026$3.66$3.91$3.66$3.8565.96K
Aug 26, 2026$3.82$3.9099$3.66$3.6630.44K
Aug 25, 2026$3.87$3.99$3.7501$3.8162.74K
Aug 24, 2026$3.77$3.95$3.55$3.92112.96K
Aug 21, 2026$3.69$3.80$3.50$3.5463.39K
Aug 20, 2026$3.51$3.86$3.51$3.68155.04K

Latest BSEM news

The latest Smart Investors Daily articles mentioning BSEM.

Stock researchCompany · Overview

BSEM research

Overview

Company profile and research snapshot.

Company profile

BIOSTEM TECHNOLOGIES NEW

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
BSEM recent ratings
DateFirmRatingTarget
Nov 7, 2022Zacks Investment ResearchBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 4, 2026

BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier

Additions extend BioStem's hospital channel to its BioRetain® wound care linePOMPANO BEACH, Fla., Sept. 04, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that VENDAJE® and VENDAJE AC® have been added to the Company's existing contracts with Vizient, Inc. and Premier, Inc., two of the nati

Yahoo · Sep 3, 2026

BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

POMPANO BEACH, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York, NY and is scheduled to attend the conference on Monday, September 14. The Company’s fireside chat

Benzinga · Aug 13, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regular session. The market value of their outstanding shares is at $7.2 million. BeyondSpring (NASDAQ:BYSI) shares moved

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By